Regeneron Pharma (REGN) PT Lowered to $888 at Barclays
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $823.82 --0%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 30
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 30
Join SI Premium – FREE
Barclays analyst Carter Gould lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $888.00 (from $915.00) while maintaining a Overweight rating.
You May Also Be Interested In
- SpaceX (SPCX) PT Raised to $280 at Oppenheimer
- Central Plaza Hotel PCL. (CENTEL:TB) PT Raised to THB47 at CLSA
- Gushengtang Holdings Ltd (2273:HK) PT Lowered to HK$38 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
